Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lung Neoplasms 3Leukemia, Myeloid, Acute 3Hematologic Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Melanoma 2Malignant Solid Neoplasm 2Hematopoietic and Lymphatic System Neoplasm 2Colorectal Neoplasms 2COVID-19 2Breast Neoplasms 2Urologic Neoplasms 1Urologic Diseases 1Spondylitis, Ankylosing 1Psoriasis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lupus Erythematosus, Systemic 1Inflammatory Bowel Diseases 1Hypogonadism 1Head and Neck Neoplasms 1HIV Infections 1Death 1Crohn Disease 1Colitis, Ulcerative 1

Interventions

Magnetic Resonance Spectroscopy 4Cyclophosphamide 4Specimen Handling 3Biopsy 3sodium-iodide symporter 2fludarabine 2cemiplimab 2X-Rays 2Whole-Body Irradiation 2Stem Cell Transplantation 2Photons 2Nivolumab 2Mycophenolic Acid 2Immunoglobulin G 2Disulfides 2Cyclosporine 2treosulfan 1ruxolitinib 1pembrolizumab 1fludarabine phosphate 1entrectinib 1duvelisib 1alectinib 1Vinblastine 1Tacrolimus 1Standard of Care 1Sirolimus 1Practice Guidelines as Topic 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Large-Cell, Anaplastic × Practice Guidelines as Topic × 30 days × Clear all
NCT06724237 2026-05-15

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Recruiting
294 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡